A 2-year survey of treatment of acute atrial fibrillation in an ED

American Journal of Emergency Medicine

Volumn 29, Issue 5, 2011, Pages 534-540

  Hirschl, Michael M ^a   Wollmann, Christian ^a   Globits, Sebastian ^a  

^a Karl Landsteiner Institute for Implementation of Innovative Techniques in Cardiac Surgery   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DIGOXIN; DILTIAZEM; FLECAINIDE; IBUTILIDE; MAGNESIUM;

ADULT; AGED; ARTICLE; BRADYCARDIA; CARDIOVERSION; CLINICAL PRACTICE; EMERGENCY WARD; FEMALE; HEALTH CARE SURVEY; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TORSADE DES POINTES; TREATMENT RESPONSE;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DIGOXIN; DILTIAZEM; EMERGENCY SERVICE, HOSPITAL; FEMALE; FLECAINIDE; HUMANS; MALE; MIDDLE AGED; SULFONAMIDES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79958064713     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2009.12.016     Document Type: Article

References (31)

1. Wolf PA, Dawber TR, Thomas HE, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978;28:973-7. (Pubitemid 8401525)
2. Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995;98:476-84.
3. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5. (Pubitemid 32424106)
4. Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997;96:2455-61. (Pubitemid 27425856)
5. Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;9:651-745. (Pubitemid 44472247)
6. Wattanasuwan N, Khan IA, Nirav JM, et al. Acute ventricular rate control in atrial fibrillation. Chest 2001;119:502-6.
7. Boriani G, Biffi M, Diemberger I, et al. Rate control in atrial fibrillation. Choice of treatment and assessment of efficacy. Drugs 2003;63:1489-509.
8. Williams E, Ansari M, Lip GYH. Managing atrial fibrillation in the accident and emergency department. QJ Med 2001;94:509-614.
9. Donovan KD, Dobb GJ, Coombs LJ, et al. Efficacy of flecainide for the reversion of acute onset atrial fibrillation. Am J Cardiol 1992;70:50A-5A.
10. Martinez-Marcos FJ, Garcia-Garmendia JL, Ortega-Carpio A, et al. Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. Am J Cardiol 2000;86:950-3.
11. Reisinger J, Gatterer E, Lang W, et al. Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset. Eur Heart J 2004;25:1318-24. (Pubitemid 38998508)
12. McNamara RL, Tamariz LJ, Segal JB, et al. Management of atrial fibrillation: review of the evidence for the role of pharmacological therapy, electrical cardioversion, and echocardiography. Ann Intern Med 2003;139:1018-33. (Pubitemid 37531534)
13. Kafkas NV, Patsilinakos SP, Mertzanos GA, et al. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter. Int J Cardiol 2007;118:321-5. (Pubitemid 46678234)
14. Varriale P, Sedighi A. Acute management of atrial fibrillation and atrial flutter in the critical care unit: should it be ibutilide? Clin Cardiol 2000;23:265-8.
15. Bianconi L, Castro A, Dinelli M, et al. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. Eur Heart J 2000;21:1265-73.
16. Galve E, Rius T, Ballester R, et al. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol 1996;27:1079-82. (Pubitemid 26117695)
17. Slavik SS. Intravenous amiodarone for acute pharmacological conversion of atrial fibrillation in the emergency department. Pharmacotherapy 2004;4:414-20.
18. Yahalom J, Klein HO, Kaplinsky E. Beta-adrenergic blockade as adjunctive oral therapy in patients with chronic atrial fibrillation. Chest 1977;71:592-6. (Pubitemid 8111559)
19. Khalsa A, Edvardsson N, Olsson SB. Effects of metoprolol on heart rate in patients with digitalis treated chronic atrial fibrillation. Clin Cardiol 1978;1:91-5. (Pubitemid 9176665)
20. Slavik RS, Tisdale JE, Borzak S. Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence. Prog Cardiovasc Dis 2001;44:121-52. (Pubitemid 32896029)
21. Tejan-Sie SA, Murray RD, Black IW, et al. Spontaneous conversion of patients with atrial fibrillation scheduled for electrical cardioversion: an ACUTE trial ancillary study. J Am Coll Cardiol 2003;42:1638-43. (Pubitemid 37378446)
22. Nichol G, McAlister F, Pham B, et al. Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. Heart 2002;87:535-43. (Pubitemid 34547976)
23. Cotter G, Blatt A, Kaluski E, et al. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. Eur Heart J 1999;20:1833-42.
24. Backer HD, Decker L, Ackerson L. Reproducibility of increased blood pressure during an emergency department or urgent care visit. Ann Emerg Med 2003;41:507-12. (Pubitemid 36373519)
25. Dieterle T, Schuurmans MM, Strobel W, Battegay EJ, Martina B. Moderate-to-severe blood pressure elevation at ED entry: hypertension or normotension? Am J Emerg Med 2005;23:474-9.
26. Thomas MC, Dublin S, Kaplan RC, et al. Blood pressure control and risk of incident atrial fibrillation. Am J Hypertens 2008;21:1111-6.
27. Mitchell GF, Vasan RS, Keyes MJ, et al. Pulse pressure and risk of new-onset atrial fibrillation. JAMA 2007;297:709-15. (Pubitemid 46294560)
28. Verdecchia P, Reboldi G, Gattobigio, et al. Atrial fibrillation in hypertension: predictors and outcome. Hypertension 2003;41:218-23. (Pubitemid 36204892)
29. Heskestad B, Baardsen R, Helseth E, et al. Guideline compliance in management of minimal, mild, and moderate head injury: high frequency of noncompliance among individual physicians despite strong guideline support from clinical leaders. J Trauma 2008;65:1309-13.
30. Tremey B, Tazarourte K, Ract C, et al. Teaching improves adherence to clinical guidelines in the treatment of oral anticoagulation-related severe bleeding in the emergency department. Intensive Care Med 2009 [Epub ahead of print].
31. Smith C, Mensah A, Mal S, et al. Is pretest probability assessment on emergency department patients with suspected venous thromboembolism documented before SimpliRED D-dimer testing? CJEM 2008;10:519-23.